)
Auna (AUNA) investor relations material
Auna Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Stabilized Mexico operations in Q4 2025, setting the stage for top-line and EBITDA growth in 2026, despite earlier volume losses; Peru outperformed with strong pricing mix and record low medical loss ratio, while Colombia delivered growth and improved cash flow through risk-sharing contracts.
Consolidated revenue for FY25 was S/4,385 million, flat year-over-year on a reported basis but up 4% FXN; Q4'25 revenue up 7% YoY to S/1,133 million, driven by strong growth in Peru and Colombia offsetting Mexico's challenges.
Adjusted net income reached S/136 million in Q4, up from S/36 million YoY; full-year adjusted net income more than doubled to S/336 million.
Free cash flow grew 35% YoY to S/582 million; year-end cash position up 42% to S/335 million, supporting liquidity.
Completed US$825 million debt refinancing, improving maturity profile, reducing interest expense, and maintaining leverage ratio at 3.6x.
Financial highlights
FY25 consolidated revenue: S/4,385 million (flat YoY reported, +4% FXN); Q4'25: S/1,133 million (+7% YoY); adjusted EBITDA for FY25: S/917 million (-8% YoY reported, -3% FXN); margin 20.9% (-1.7 p.p. YoY); Q4'25 adjusted EBITDA: S/220 million (-13% YoY), margin 19.5% (-4.5 p.p. YoY).
Adjusted net income: S/336 million for FY25 (+130% YoY); S/136 million for Q4'25.
Free cash flow: S/582 million (+35% YoY); end-of-period cash: S/335 million (+42% YoY).
Net finance costs in FY25 S/436 million vs S/609 million in FY24; excluding extraordinary items, down 18.2%.
Gross margin for FY25: 37.9% (-1.4 p.p. YoY).
Outlook and guidance
2026 revenue and adjusted EBITDA growth expected at 12% FXN, within a 10–14% range, driven by commercial momentum, operational execution, and disciplined cost management.
CapEx expected to remain at approximately 4% of revenue, focused on maintenance, infrastructure, and IT investments.
Guidance based on current macroeconomic and regulatory assumptions; subject to change if conditions shift.
Mexico and Peru identified as primary growth engines over the next five years.
- Adjusted EBITDA up 31% and revenue up 18% year-over-year, with leverage ratio at 4.13x.AUNA
Q2 202423 Jan 2026 - Adjusted EBITDA up 23% YoY, leverage ratio at 3.7x, and OncoMexico pilot advancing.AUNA
Q3 202413 Jan 2026 - Healthcare group targets $1B NYSE offering to expand Latin American operations.AUNA
Registration Filing16 Dec 2025 - Healthcare group seeks up to $1B in NYSE-listed shares to fund growth in Latin America.AUNA
Registration Filing16 Dec 2025 - FY24 Adjusted EBITDA up 20.1% FXN, margin and net income improved, leverage at 3.6x.AUNA
Q4 20243 Dec 2025 - Peru's growth offset Mexico and Colombia's declines, sustaining profitability and stable leverage.AUNA
Q1 202526 Nov 2025 - Adjusted EBITDA up 5% FXN YoY; net income surged; leverage steady amid FX headwinds.AUNA
Q2 202523 Nov 2025 - Peru and Colombia grew, Mexico declined; leverage stable, refinancing done, Mexico recovery in 2026.AUNA
Q3 202521 Nov 2025
Next Auna earnings date
Next Auna earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)